← FDA ENFORCEMENT
D-0961-2023Class II

Central Admixture Pharmacy Services, Inc.

Recalling firm
Central Admixture Pharmacy Services, Inc.
Product type
Drug
Status
Terminated
Report date
2023-08-09
Distribution
Nationwide in the USA
Firm state
AZ
Product quantity
8,363 bags
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental Monitoring
Reason for recall

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Product description

PHENYLephrine 20mg/250ml added to 0.9% sodium chloride, IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-7025-1.

Code / lot info

Lot:36-239194, 36-239195, Exp.7/10/2023; 36-240009, Exp. 7/13/2023; 36-240799, Exp.7/17/2023; 36-241147, 36-241148, Exp. 7/19/2023; 36-241740, 36-241741, Exp. 7/21/2023; 36-242562, Exp. 7/25/2023; 36-243531, Exp. 7/30/2023; 36-244886, 36-244961, Exp. 8/1/2023; 36-246713, 36-246714, 36-24671, 536-246716, Exp. 8/6/2023; 36-247344, 36-247345, 36-247347, 36-247348, 36-247349, 36-247350, Exp. 8/8/2023; 36-247823, 36-247824, 36-247825, 36-247826, Exp. 8/10/2023; 36-248356, 36-248358, Exp. 8/11/2023; 36-249226, Exp. 8/17/2023; 36-251966, Exp. 8/30/2023.

Other recalls SPEQ maps to Environmental Monitoring
2026-07-22Class IArgon Medical Devices, Inc2026-07-22Class IIOlympus Corporation of the Americas2026-07-22Class IIChiesi USA, Inc.2026-07-22Class IICareFusion 213, LLC
See all Environmental Monitoring recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.